By using our website, you agree to the use of our cookies.

News

Rhenman & Partners wins prestigious award at the Nordic Hedge Awards: Best Performance Awards for 5 Years

Since inception in June 2009, the fund has had annualised returns of +19%
The sector fund Rhenman Healthcare Equity L/S was named a winner at this year’s Nordic
Hedge Awards; best-performing Nordic hedge fund for five years. The award was made in
the category “Performance Award for 60 Months”.
“We are tremendously pleased over this award. The Nordic Hedge Award is the most prestigious
Nordic award for hedge funds and a total of 172 funds were evaluated in 2018. To put it simply,
this is the Nordic championship and to win the category for the longest time period is a testament to
our unique investment process which leads the way, even internationally,” says Carl Grevelius, cofounder and head of investor relations.
“Our success depends largely on the many years of close collaboration between our fund managers
and the medical experts in our Scientific Advisory Board. Equally important is our investment team’s
single focus on the healthcare sector which includes pharmaceuticals, biotechnology, medical
technology and service. This sectoral focus probably gives us a knowledge advantage compared to
those investors who monitor and invest in a number of sectors.”
Rhenman Healthcare Equity L/S has an unprecedented performance history since its inception in
June 2009. The main fund class, the IC1 (EUR), has increased by 449 percent in total, which
corresponds to an average annual net return of 19 percent. In the first quarter 2019, the fund
delivered a return of more than 15 percent. At present, assets under management in
the fund exceed 600 million EUR.
For further information, please contact:
Carl Grevelius, Founding Partner / Head of Investor Relations
Phone: +46 8 459 88 83
Email: carl@rhepa.com
www.rhepa.com

About Rhenman & Partners
Rhenman & Partners Asset Management, founded in 2008, is a Stockholm-based asset manager
focusing on two niche funds: Rhenman Healthcare Equity L/S, launched in June 2009,
and Rhenman Global Opportunities L/S, launched in August 2016. Assets under
management exceed 600 MEUR. The management teams of the two funds are supported in their
respective investment processes by renowned advisors consisting of, among others,
eminent professors and experts with many years of market experience and extensive expert
networks around the world